Thus, the effects of insulin and insulin resistance on the BFCS and related cognition is of great relevance for ameliorating insulin resistance-dependent impairment of cognition observed in both neurodegenerative disorders (e.g. AD) and metabolic diseases (e.g. Type 2 Diabetes, T2D). The gene discussed is INS; the disease is metabolic disease.